NVAX

NOVAVAX INC

Healthcare | Mid Cap

-$0.86

EPS Forecast

$54.71

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
NBIXNeurocrine Biosciences IncTECHBio-techne CorpHALOHalozyme Therapeutics IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics IncMRNAModerna IncREPLReplimune Group IncRGENRepligen Corp